MAM
DDB Remedy launches in India through DDB Health & Lifestyle
Mumbai: The healthcare practice of the DDB Network, DDB Remedy, has launched in India through DDB Mudra Group’s Health and Lifestyle practice, DDB Health & Lifestyle (DDB H&L).
DDB H&L has aligned itself to the DDB Network and hence will be rechristened DDB Remedy India.
The rechristening gives DDB Remedy India the ability to be an integral part of the global fraternity of the DDB Remedy Network and therefore allows it to leverage global experience in an increasingly connected healthcare world. The agency will continue to build on its spheres of excellence viz. Healthcare Services Communication, Diagnostic and Devices Brand Building, FMHG and OTC Strategising, Rx or Doctor Office Brand Campaigns and Development Communication.
DDB Remedy in India will harness the inherent talents of digital, CRM, branding, experiential, media, retail, PR and production solutions within the DDB Mudra Group and DDB network overseas and provide ‘Total Branding & Communications Solutions’ to its clients in the healthcare and social change world.
DDB Remedy was launched in 2010 by the New York offices of DDB Worldwide.
DB Remedy India president Soumitra Sen said, “We are proud to be aligned with the global network and feel confident that we can now bring in best practices, knowledge and experience to work on healthcare brands here. Our vision of being the most passionate and versatile healthcare communication agency in India strengthens further with our membership to the DDB Remedy network.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
